查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828119

2025年葡萄糖生物感測器全球市場報告

Glucose Biosensors Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，葡萄糖生物感測器市場規模強勁成長，從2024年的152.6億美元成長到2025年的167.2億美元，複合年成長率為9.6%。過去一段時間的成長可歸因於研發、成本效益、使用者友善設計、糖尿病盛行率的上升、與智慧型裝置的整合以及非侵入式監測技術。

預計未來幾年，葡萄糖生物感測器市場將快速成長，到2029年將達到271.5億美元，複合年成長率為12.9%。預測期內的成長可歸因於個人化醫療解決方案、糖尿病盛行率上升、持續血糖監測的普及、與穿戴式技術的整合以及非侵入性監測技術的發展。預測期內的主要趨勢包括環保生物感測器設計、互聯互通和資料共用、增強型家庭醫療保健、非侵入性監測技術以及可植入生物感測器。

葡萄糖生物感測器是一種專門用於測量各種樣本中血糖濃度的裝置，這些樣本通常存在於血液和組織液等生物體液中。葡萄糖生物感測器在醫療保健領域有著廣泛的應用，尤其是在糖尿病管理領域，可以方便、頻繁地監測血糖值。

葡萄糖生物感測器的主要產品類別包括持續血糖監測、自我管理血糖監測和非侵入性血糖監測。持續血糖監測 (CGM) 使用植入皮下的小型感測器來測量患者的內部血糖濃度。與標準的指尖血糖監測相比，這種方法可以更全面地了解血糖濃度並提供即時結果。主要使用的技術包括電化學生物感測器、光學生物感測器和壓電感測器。這些生物感測器用於各種終端使用者應用，包括醫院、居家醫療、診斷中心和診所。

2025年春季美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供葡萄糖生物感測器市場統計數據，例如全球市場規模、各地區市場佔有率、各競爭對手的市場佔有率、詳細的葡萄糖生物感測器細分市場、市場趨勢和商機，以及您在葡萄糖生物感測器行業取得成功所需的數據。本葡萄糖生物感測器市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全方位觀點。

未來五年的預測成長率為12.9%，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這可能會直接影響美國，因為美國對來自丹麥和新加坡等主要地區的酵素塗層電極和連續血糖監測感測器徵收關稅，從而導致血糖監測準確度降低，糖尿病技術成本上升。此外，由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

預計糖尿病盛行率的上升將在未來幾年推動葡萄糖生物感測器市場的成長。糖尿病是一種由胰臟胰島素分泌不足或身體無法有效利用分泌的胰島素所引起的慢性疾病。透過利用葡萄糖生物感測器定期監測血糖值，糖尿病患者可以更有效地管理病情並根據需要調整藥物。例如，2024 年 6 月，英國管理機構 NHS England 報告稱，2023 年在其全科醫生處登記的 3,615,330 人被確診患有非糖尿病性高血糖症（俗稱糖尿病前期），比 2022 年的 3,065,825 人增加了近 18%。因此，糖尿病盛行率的上升是推動葡萄糖生物感測器市場擴張的關鍵因素。

預計老齡化人口的增加將有助於葡萄糖生物感測器市場的成長。在老年人口比例不斷增加的老齡化社會中，葡萄糖生物感測器有利於透過早期發現、遠端監控和全面的健康管理來支持有效的糖尿病管理。根據世界衛生組織（WHO）2022年10月的報告，到2030年，全球整體六分之一的人將年齡在60歲或以上，到2050年這個年齡層的人口將達到21億人。在英國，英國國會下議院圖書館於2021年6月發布的預測顯示，到2043年，老年人將佔總人口的24%，達到1740萬人。因此，老齡化人口的增加是推動葡萄糖生物感測器市場成長的關鍵因素。

葡萄糖生物感測器市場的主要企業正致力於推出創新產品來支援糖尿病患者，尤其是血糖監測系統。這些系統旨在持續測量血糖值並提供即時數據，幫助患者更有效地管理病情。例如，美國生技公司 DexCom Inc. 於 2024 年 10 月宣布推出 Stelo 葡萄糖生物感測器系統。該系統因成為美國食品藥物管理局(FDA)核准的首個非處方 (OTC) 連續血糖監測儀 (CGM) 而聞名。 Stelo 系統適用於 18 歲及以上未使用胰島素的成年人，包括第 2 型糖尿病患者或糖尿病前期患者。非糖尿病患者也可以使用它來監測血糖濃度，以便更好地了解飲食和運動對血糖值的影響。

為了豐富產品系列併擴大市場範圍，葡萄糖生物感測器市場的主要企業正專注於推出創新產品，例如 GlucoMen Day 連續血糖監測 (CGM) 系統。 GlucoMen Day CGM 系統是一種即時皮下連續血糖監測系統，旨在幫助糖尿病患者有效管理血糖值。該系統為追蹤血糖波動的傳統指摘方法提供了一種更方便、更準確的替代方法。 2022 年 4 月，匈牙利醫療設備製造商 77 Elektronika Kft. 與義大利診斷公司 A. Menarini Diagnostics 合作推出了 GlucoMen Day 連續血糖監測 (CGM) 系統。 GlucoMen Day CGM 系統是糖尿病管理技術的一項顯著進步，為使用者提供有關血糖濃度的寶貴見解，並使他們能夠做出明智的決定，以更好地控制糖尿病。這種創新系統有可能改善糖尿病患者的生活品質並減輕這種慢性病的負擔。

2023年5月，總部位於愛爾蘭的醫療設備製造商Medtronic）以7.38億美元完成對EOFLOW的收購。透過此次策略收購，Medtronic旨在拓展治療選擇，滿足謹慎給藥的需求，並鞏固其市場地位。 EOFLOW株式會社是一家韓國醫療設備製造商，專門從事穿戴式藥物輸送系統的開發和製造。

葡萄糖生物感測器市場的主要參與企業包括雅培實驗室、DexCom Inc.、F. Hoffmann-La Roche AG、GlySens Incorporated、Trividia Health、拜耳公司、LifeScan Inc.、美敦力公司、Nova Biomedical Corporation、Senseonics Holdings、ACON Laboratories Inc.、AMMatrix Inc.、AwConet. Inc.、杜邦公司、Biosensors International Group Ltd.、Cytiva、Universal Biosensors Inc.、CARDEA BIO INC.、Conductive Technologies Inc.、EarlySense Inc.、Innovative Sensor Technology IST AG、LifeSignals Inc.、NeuroSky Inc.、SD Biosensor INC.、Xdocsenio 和 Taidoc Technology。

2024年葡萄糖生物感測器市場最大的地區是北美。葡萄糖生物感測器市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。

葡萄糖生物感測器市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

葡萄糖生物感測器市場涵蓋磁性生物感測器、溫度生物感測器、電位感測器、安培感測器和電導率感測器的銷售。該市場的價值指的是“出廠價”，即產品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球葡萄糖生物感測器：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球葡萄糖生物感測器市場：成長率分析
  • 全球葡萄糖生物感測器市場表現：規模與成長，2019-2024
  • 全球葡萄糖生物感測器市場預測：規模與成長，2024-2029年，2034年
  • 全球葡萄糖生物感測器：總目標市場（TAM）

第6章 市場細分

  • 全球葡萄糖生物感測器市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 持續血糖監測（CGM）
  • 自我血糖監測（SMBG）
  • 非侵入性血糖監測
  • 全球葡萄糖生物感測器市場技術、性能及預測（2019-2024、2024-2029、2034）
  • 電化學生物感測器
  • 光學生物感測器
  • 壓電生物感測器
  • 其他
  • 全球葡萄糖生物感測器市場終端用戶、效能及預測（2019-2024、2024-2029、2034）
  • 醫院
  • 居家醫療
  • 診斷中心和診所
  • 其他
  • 全球葡萄糖生物感測器市場：連續血糖監測 (CGM) 細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 即時CGM系統
  • 專業CGM系統
  • 胰島素幫浦整合
  • 感測器類型
  • 全球葡萄糖生物感測器市場：自我血糖監測（SMBG）細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 血糖儀
  • 測試條
  • 血液樣本類型
  • 全球葡萄糖生物感測器市場：非侵入式葡萄糖監測細分市場、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 光學葡萄糖感測器
  • 經皮感應器
  • 穿戴式裝置

第7章 區域和國家分析

  • 全球葡萄糖生物感測器市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
  • 全球葡萄糖生物感測器市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 葡萄糖生物感測器市場：競爭格局
  • 葡萄糖生物感測器市場：公司簡介
    • Abbott Laboratories
    • DexCom Inc.
    • F. Hoffmann-La Roche AG
    • GlySens Incorporated
    • Trividia Health

第31章：其他領先和創新企業

  • Bayer AG
  • LifeScan Inc.
  • Medtronic plc
  • Nova Biomedical Corporation
  • Senseonics Holdings
  • ACON Laboratories Inc.
  • AgaMatrix Inc.
  • Ypsomed AG
  • Ascencia Diabetes Care Holdings Inc.
  • Bio-Rad Laboratories Inc.
  • DuPont de Nemours Inc.
  • Biosensors International Group Ltd.
  • Cytiva
  • Universal Biosensors Inc.
  • CARDEA BIO INC.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年葡萄糖生物感測器市場：提供新機會的國家
  • 2029年葡萄糖生物感測器市場：細分市場將帶來新機會
  • 2029年葡萄糖生物感測器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24169u

A glucose biosensor is a specialized device designed for measuring glucose levels in different samples, commonly found in biological fluids such as blood or interstitial fluid. Widely applied in healthcare, especially for diabetes management, these biosensors facilitate convenient and frequent monitoring of blood glucose levels.

The primary product categories for glucose biosensors include continuous glucose monitoring, self-monitoring blood glucose, and non-invasive glucose monitoring. Continuous glucose monitoring (CGM) involves using a miniature sensor implanted under the skin to measure glucose levels in the patient's body. This method offers a more comprehensive view of glucose levels compared to standard fingerstick glucose monitoring and provides real-time results. The technologies predominantly used are electrochemical biosensors, optical biosensors, piezoelectric biosensors, and others. These biosensors find applications across various end-users such as hospitals, home care, diagnostic centers, clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The glucose biosensors market research report is one of a series of new reports from The Business Research Company that provides glucose biosensors market statistics, including glucose biosensors industry global market size, regional shares, competitors with a glucose biosensors market share, detailed glucose biosensors market segments, market trends and opportunities, and any further data you may need to thrive in the glucose biosensors industry. This glucose biosensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glucose biosensors market size has grown strongly in recent years. It will grow from $15.26 billion in 2024 to $16.72 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to research and development, cost-efficiency, user-friendly design, increasing diabetes prevalence, integration with smart devices, non-invasive monitoring techniques.

The glucose biosensors market size is expected to see rapid growth in the next few years. It will grow to $27.15 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to personalized healthcare solutions, rise in diabetes cases, continuous glucose monitoring expansion, integration with wearable tech, non-invasive monitoring development. Major trends in the forecast period include eco-friendly biosensor designs, interconnectivity and data sharing, home healthcare empowerment, non-invasive monitoring techniques, implantable biosensors.

The forecast of 12.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on enzyme-coated electrodes and continuous glucose monitoring transmitters, sourced from key regions such as Denmark and Singapore, which could lead to compromised glycemic monitoring accuracy and increased costs for diabetes technology.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is projected to drive the growth of the glucose biosensors market in the coming years. Diabetes is a chronic condition that occurs when the pancreas does not produce sufficient insulin or when the body is unable to effectively use the insulin produced. Patients with diabetes rely on glucose biosensors to regularly monitor their blood glucose levels, allowing them to manage their condition more effectively and adjust their medication as needed. For example, in June 2024, NHS England, a governing body in the UK, reported that in 2023, 3,615,330 individuals registered with a GP were identified as having non-diabetic hyperglycemia, commonly known as pre-diabetes, which reflects an increase from 3,065,825 in 2022-an almost 18% rise. Therefore, the growing prevalence of diabetes is a significant factor driving the expansion of the glucose biosensors market.

The increasing aging population is anticipated to contribute to the growth of the glucose biosensor market. The aging population, characterized by a rising proportion of elderly individuals, benefits from glucose biosensors that support effective diabetes management through early detection, remote monitoring, and overall well-being. According to the World Health Organization's October 2022 report, globally, one in six people will be 60 or older by 2030, with the number of individuals in this age group reaching 2.1 billion by 2050. In the United Kingdom, projections from the UK Parliament's House of Commons Library in June 2021 indicate that by 2043, the senior population will constitute 24% of the total population, amounting to 17.4 million people. Therefore, the growing aging population is a significant factor driving the growth of the glucose biosensor market.

Leading companies in the glucose biosensor market are concentrating on innovative product launches, particularly glucose monitoring systems, to assist individuals with diabetes. These systems are designed to continuously measure and provide real-time data on blood glucose levels, helping individuals manage their condition more effectively. For instance, in October 2024, DexCom Inc., a biotechnology company based in the United States, introduced the Stelo Glucose Biosensor System. This system is notable for being the first over-the-counter (OTC) continuous glucose monitor (CGM) approved by the U.S. Food and Drug Administration (FDA). The Stelo system is intended for adults aged 18 and older who do not use insulin, including those with Type 2 diabetes or prediabetes. It can also be utilized by individuals without diabetes who want to monitor their glucose levels to better understand how their diet and exercise impact blood sugar.

Major companies in the glucose biosensor market are emphasizing innovative product launches, exemplified by the introduction of the GlucoMen Day continuous glucose monitoring (CGM) system, to diversify their product portfolio and broaden market outreach. The GlucoMen Day CGM system, a real-time subcutaneous continuous glucose monitoring system, is designed to assist individuals with diabetes in effectively managing their blood sugar levels. This system offers a more convenient and accurate alternative for tracking glucose fluctuations compared to traditional finger-pricking methods. In April 2022, 77 Elektronika Kft., a Hungary-based medical equipment manufacturer, introduced the glucomen day continuous glucose monitoring (CGM) system in collaboration with A. Menarini Diagnostics, an Italy-based diagnostics company. The glucomen day CGM system represents a notable advancement in diabetes management technology, providing users with valuable insights into their glucose levels and empowering them to make informed decisions for better diabetes control. This innovative system has the potential to enhance the quality of life for people with diabetes and alleviate the burden of this chronic condition.

In May 2023, Medtronic plc, an Ireland-based medical device company, completed the acquisition of EOFLOW Co., Ltd. for $738 million. Through this strategic acquisition, Medtronic plc aims to broaden treatment options, cater to the demand for discreet delivery, and strengthen its position in the market. EOFLOW Co. Ltd. is a South Korea-based medical device company specialized in developing and manufacturing wearable drug delivery systems.

Major companies operating in the glucose biosensors market include Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, GlySens Incorporated, Trividia Health, Bayer AG, LifeScan Inc., Medtronic plc, Nova Biomedical Corporation, Senseonics Holdings, ACON Laboratories Inc., AgaMatrix Inc., Ypsomed AG, Ascencia Diabetes Care Holdings Inc., Bio-Rad Laboratories Inc., DuPont de Nemours Inc., Biosensors International Group Ltd., Cytiva, Universal Biosensors Inc., CARDEA BIO INC., Conductive Technologies Inc., EarlySense Inc., Innovative Sensor Technology IST AG, LifeSignals Inc., NeuroSky Inc., SD Biosensor INC., Xsensio, Taidoc Technology Corporation

North America was the largest region in the glucose biosensors market in 2024. The regions covered in the glucose biosensors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the glucose biosensors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The glucose biosensors market consists of sales of magnetic biosensors, thermometric biosensors, potentiometric, amperometric, and conductometric sensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glucose Biosensors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glucose biosensors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glucose biosensors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The glucose biosensors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Continuous Glucose Monitoring; Self-monitoring Blood Glucose; Non-invasive Glucose Monitoring
  • 2) By Technology: Electrochemical Biosensors; Optical Biosensors; Piezoelectric Biosensors; Others Technologies
  • 3) By End Users: Hospitals; Home Care; Diagnostic Centers and Clinics; Other End Users
  • Subsegments:
  • 1) By Continuous Glucose Monitoring (CGM): Real-time CGM systems; Professional CGM systems; Integration with insulin pumps; Sensor types
  • 2) By Self-monitoring Blood Glucose (SMBG): Glucometers; Test strips; Blood sample types
  • 3) By Non-invasive Glucose Monitoring: Optical glucose sensors; Transdermal sensors; Wearable devices
  • Companies Mentioned: Abbott Laboratories; DexCom Inc.; F. Hoffmann-La Roche AG; GlySens Incorporated; Trividia Health; Bayer AG; LifeScan Inc.; Medtronic plc; Nova Biomedical Corporation; Senseonics Holdings; ACON Laboratories Inc.; AgaMatrix Inc.; Ypsomed AG; Ascencia Diabetes Care Holdings Inc.; Bio-Rad Laboratories Inc.; DuPont de Nemours Inc.; Biosensors International Group Ltd.; Cytiva; Universal Biosensors Inc.; CARDEA BIO INC.; Conductive Technologies Inc.; EarlySense Inc.; Innovative Sensor Technology IST AG; LifeSignals Inc.; NeuroSky Inc.; SD Biosensor INC.; Xsensio; Taidoc Technology Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Glucose Biosensors Market Characteristics

3. Glucose Biosensors Market Trends And Strategies

4. Glucose Biosensors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Glucose Biosensors Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Glucose Biosensors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Glucose Biosensors Market Growth Rate Analysis
  • 5.4. Global Glucose Biosensors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Glucose Biosensors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Glucose Biosensors Total Addressable Market (TAM)

6. Glucose Biosensors Market Segmentation

  • 6.1. Global Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Glucose Monitoring
  • Self-monitoring Blood Glucose
  • Non-invasive Glucose Monitoring
  • 6.2. Global Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electrochemical Biosensors
  • Optical Biosensors
  • Piezoelectric Biosensors
  • Other Technologies
  • 6.3. Global Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Home Care
  • Diagnostic Centers and Clinics
  • Other End Users
  • 6.4. Global Glucose Biosensors Market, Sub-Segmentation Of Continuous Glucose Monitoring (CGM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Real-time CGM systems
  • Professional CGM systems
  • Integration with insulin pumps
  • Sensor types
  • 6.5. Global Glucose Biosensors Market, Sub-Segmentation Of Self-monitoring Blood Glucose (SMBG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glucometers
  • Test strips
  • Blood sample types
  • 6.6. Global Glucose Biosensors Market, Sub-Segmentation Of Non-invasive Glucose Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Optical glucose sensors
  • Transdermal sensors
  • Wearable devices

7. Glucose Biosensors Market Regional And Country Analysis

  • 7.1. Global Glucose Biosensors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Glucose Biosensors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glucose Biosensors Market

  • 8.1. Asia-Pacific Glucose Biosensors Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glucose Biosensors Market

  • 9.1. China Glucose Biosensors Market Overview
  • 9.2. China Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glucose Biosensors Market

  • 10.1. India Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glucose Biosensors Market

  • 11.1. Japan Glucose Biosensors Market Overview
  • 11.2. Japan Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glucose Biosensors Market

  • 12.1. Australia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glucose Biosensors Market

  • 13.1. Indonesia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glucose Biosensors Market

  • 14.1. South Korea Glucose Biosensors Market Overview
  • 14.2. South Korea Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glucose Biosensors Market

  • 15.1. Western Europe Glucose Biosensors Market Overview
  • 15.2. Western Europe Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glucose Biosensors Market

  • 16.1. UK Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glucose Biosensors Market

  • 17.1. Germany Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glucose Biosensors Market

  • 18.1. France Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glucose Biosensors Market

  • 19.1. Italy Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glucose Biosensors Market

  • 20.1. Spain Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glucose Biosensors Market

  • 21.1. Eastern Europe Glucose Biosensors Market Overview
  • 21.2. Eastern Europe Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glucose Biosensors Market

  • 22.1. Russia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glucose Biosensors Market

  • 23.1. North America Glucose Biosensors Market Overview
  • 23.2. North America Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glucose Biosensors Market

  • 24.1. USA Glucose Biosensors Market Overview
  • 24.2. USA Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glucose Biosensors Market

  • 25.1. Canada Glucose Biosensors Market Overview
  • 25.2. Canada Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glucose Biosensors Market

  • 26.1. South America Glucose Biosensors Market Overview
  • 26.2. South America Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glucose Biosensors Market

  • 27.1. Brazil Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glucose Biosensors Market

  • 28.1. Middle East Glucose Biosensors Market Overview
  • 28.2. Middle East Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glucose Biosensors Market

  • 29.1. Africa Glucose Biosensors Market Overview
  • 29.2. Africa Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glucose Biosensors Market Competitive Landscape And Company Profiles

  • 30.1. Glucose Biosensors Market Competitive Landscape
  • 30.2. Glucose Biosensors Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GlySens Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Trividia Health Overview, Products and Services, Strategy and Financial Analysis

31. Glucose Biosensors Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. LifeScan Inc.
  • 31.3. Medtronic plc
  • 31.4. Nova Biomedical Corporation
  • 31.5. Senseonics Holdings
  • 31.6. ACON Laboratories Inc.
  • 31.7. AgaMatrix Inc.
  • 31.8. Ypsomed AG
  • 31.9. Ascencia Diabetes Care Holdings Inc.
  • 31.10. Bio-Rad Laboratories Inc.
  • 31.11. DuPont de Nemours Inc.
  • 31.12. Biosensors International Group Ltd.
  • 31.13. Cytiva
  • 31.14. Universal Biosensors Inc.
  • 31.15. CARDEA BIO INC.

32. Global Glucose Biosensors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glucose Biosensors Market

34. Recent Developments In The Glucose Biosensors Market

35. Glucose Biosensors Market High Potential Countries, Segments and Strategies

  • 35.1 Glucose Biosensors Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Glucose Biosensors Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Glucose Biosensors Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer